期刊文献+

子宫内膜癌FIGO 2009分期中Ⅰ期的临床意义 被引量:6

Clinical significance of FIGO 2009 staging Ⅰ and its prognostic related factors in endometrial carcinoma
原文传递
导出
摘要 目的 探讨子宫内膜癌国际妇产科联盟2009年(FIGO 2009)分期中Ⅰ期的临床意义.方法 收集北京大学人民医院1998年12月至2009年12月间收治的FIGO 2009分期为Ⅰ期,随访资料较完整且行全面分期手术的子宫内膜癌患者233例,FIGO 2009分期中将FIGO 1988分期中的Ⅰ a期及Ⅰb期归为Ⅰa期,Ⅰc期归为Ⅰb期,将子宫颈腺体受累(Ⅱa期)归为Ⅰ期并根据其肌层浸润深度确定归为Ⅰa期或者Ⅰb期,取消FIGO 1988分期中的Ⅰ c期.对照FIGO 1988分期,回顾性分析与FIGO 1988分期相关的临床病理因素.结果 233例FIGO 2009分期为Ⅰ期的子宫内膜癌患者中,FIGO 1988分期为Ⅰa期41例、Ⅰb期146例、Ⅰc期29例、Ⅱa期17例.对FIGO 1988分期中Ⅰa期、Ⅰb期进行分析显示,病理分级、病理类型、脉管内癌栓、ER、PR表达、术后化疗及术后放化疗与Ⅰa期、Ⅰb期分期均无明显相关性(P均>0.05);而肌层浸润深度与Ⅰ a期、Ⅰb期分期密切相关(P=0.000).对FIGO 1988分期中Ⅰ期、Ⅱa期进行分析显示,病理分级、病理类型、脉管内癌栓、肌层浸润、ER、PR表达、术后化疗及术后放化疗与Ⅰ期、Ⅱa期分期均无明显相关性(P均>0.05).结论 子宫内膜癌FIGO 2009新分期中的Ⅰ期较FIGO 1988分期中的Ⅰ期和Ⅱa期更符合患者的实际临床状况. Objective To discuss the clinical significance of Federation International of Gynecology and Obstetrics (FIGO) 2009 staging Ⅰ and its prognostic related factors in endometrial carcinoma.Methods A retrospective analysis was carried out on 233 cases with FIGO 2009 staging Ⅰ endometrial carcinoma who were admitted to Department of Obstetrics and Gynecology,Peking University People's Hospital from Dec.1998 to Dec.2009 and were carried with complete staging operation then compared with FIGO 1988 staging.All follow-up data were complete.Results Of the 233 cases,including FIGO 1988 staging Ⅰ a 41 cases,Ⅰ b 146 cases,Ⅰ c 29 cases and Ⅱ a 17 cases.The univariate analysis revealed that there were no significant difference between staging Ⅰ a and Ⅰ b group in histological grade,pathological type,intravascular vessel cancer embolus,the expression of ER,PR,postoperative chemotherapy or postoperative chemoradiotherapy (all P〉0.05).The univariate analysis revealed that there were no significant difference between staging Ⅰ and Ⅱ a group in histological grade,pathological type,intravascular vessel cancer embolus,the depth of myometrial invasion,the expression of ER and PR postoperative chemotherapy or postoperative chemoradiotherapy (all P〉0.05).Conclusion FIGO 2009 staging Ⅰ in endometrial carcinoma is more consistent with the patient's clinical status than that in FIGO 1988 stage Ⅰ and Ⅱa.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第10期776-779,共4页 Chinese Journal of Obstetrics and Gynecology
关键词 子宫内膜肿瘤 肿瘤分期 肿瘤浸润 Endometrial neoplasms Neoplasm staging Neoplasm invasiveness
  • 相关文献

参考文献10

  • 1Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet,2009,105: 103-104.
  • 2曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2005:2600.
  • 3Steiner E, Eicher O, Sagemtiller J, et al. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University[J]. Int J Gynecol Cancer,2003,13:197-203.
  • 4Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: muhicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma[J]. Lancet,2000,355:1404-1411.
  • 5Creutzberg CL, van Putten WL, W6rl6m-Rodenhuis CC, et al. Outcome of high-risk stage ] C, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial[J]. J Clin Oncol,2004, 22:1234-1241.
  • 6Scholten AN, van Puttcn WL, Beerman H, et al. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review[J]. Int J Radiat Oncol Biol Phys,2005,63:834-838.
  • 7Hong JJ, Yacoub SF, Blevins JC, ei al. High dose rate vaginal braehytherapy in early stage endometrial carcinoma: preliminary analysis[J]. Am J Clin Oncol, 1997,20:254-258.
  • 8Boz G, De Paoli A, Innocente R, et al. Endometrial stage I carcinoma treated with surgery and adjuvant irradiation: a retrospective analysis[J]. Tumori,1995,81:256-260.
  • 9屠铮,商宇红,富琪,王建六,魏丽惠.Ⅰ、Ⅱ期子宫内膜癌复发病例的特征与预后[J].中国妇产科临床杂志,2003,4(2):113-116. 被引量:3
  • 10Werner HM, Trovik J, Marcickiewicz J, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification[J]. Gynecol 0ncol,2012,125:103-108.

二级参考文献16

  • 1[1]Feltmate CM. Duska LR, Chang Y, et al. Predictors of recurrence in surgical stage Ⅱ endometrial adenocarcinoma. Gynecol Oncol, 1999, 73:407 - 411
  • 2[2]Ackerman I, Malone S, Thomas G, et al. Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol, 1996, 60: 177- 183
  • 3[3]Descamps P, Calais G, Moire C, et al. Predictors of distant recurrence in clinical stage Ⅰ or Ⅱ endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol, 1997, 64:54-58
  • 4[4]CrentzberyCL, vanPuttenWL, KoperPC, etal. Surgery and postoperative radiotherapy versus surgery alone for patients with stage - 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet, 2000,355: 1404- 1411
  • 5[5]Sakuragi N, Hareyama H, Todo Y, et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand, 2000, 79:311 -316
  • 6[7]Tewari K, Cappuccini F, Brewster WR, et al. Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. Gynecol Oncol, 1999,74:416-422
  • 7[8]Jereczek FB, Badzio A, Jassem J. Recurrent endometrial cancer after surgery alone: results of salvage radiotherpy.Int J Radiat Oncol Biol Phys, 2000, 48:405-413
  • 8[9]Ogawa K, Toita T, Kakinohana Y, et al. Palliative radiation therapy for brain metastases from endometrial carcinoma: report of two cases. Jpn J Clin Oncol, 1999, 29:498-503
  • 9[10]Scarabelli C, Campagnutta E, Giorda G, et al. Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma. Gynecol Oncol, 1998, 70:90-93
  • 10[11]Bouros D, Papadakis K, Siafakas N, et al. Natural history of patients with pulmonary metastases from uterine cancer. Cancer, 1996, 78:441 - 447

共引文献281

同被引文献56

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部